Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Онікс Терап'Ютікс, Інк.filedCriticalОнікс Терап'Ютікс, Інк.
Publication of UA110609C2publicationCriticalpatent/UA110609C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
One aspect of the invention relates to inhibitors which inhibit the activity mainly imunoproteasomy relatively constitutive proteasome activity. In certain embodiments, the present invention relates to the treatment of immune-related diseases, comprising administering a compound of the present invention. In certain embodiments, the present invention relates to the treatment of cancer, comprising administering a compound of the present invention.
UAA201209116A2007-06-192007-06-19Compounds for inhibition of the enzyme proteasome
UA110609C2
(en)
Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity